Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia

Authors

  • Robert H. Fletcher MD, MSc,

    1. Department of Ambulatory Care and Prevention, Harvard Medical School Cambridge, Massachusetts
    Search for more papers by this author
    • From 1998 to 2002, David Ransohoff was chair of the Scientific Advisory Board of Exact Sciences. Thomas Imperiale is a consultant for Exact Sciences. Robert Fletcher is a member of the Scientific Advisory Board of Exact Sciences, which has developed a DNA-based stool test for colorectal cancer.

  • David F. Ransohoff MD,

    1. Division of Gastroenterology, Department of Medicine, University of North Carolina Chapel Hill, North Carolina
    Search for more papers by this author
    • From 1998 to 2002, David Ransohoff was chair of the Scientific Advisory Board of Exact Sciences. Thomas Imperiale is a consultant for Exact Sciences. Robert Fletcher is a member of the Scientific Advisory Board of Exact Sciences, which has developed a DNA-based stool test for colorectal cancer.

  • Thomas F. Imperiale MD

    1. Division of Gastroenterology, Department of Medicine, Indiana University School of Medicine Indianapolis, Indiana
    Search for more papers by this author
    • From 1998 to 2002, David Ransohoff was chair of the Scientific Advisory Board of Exact Sciences. Thomas Imperiale is a consultant for Exact Sciences. Robert Fletcher is a member of the Scientific Advisory Board of Exact Sciences, which has developed a DNA-based stool test for colorectal cancer.


No abstract is available for this article.

Ancillary